Search results
FTSE 100 Live 21 May: Inflation in focus after index closes slightly down
Evening Standard via Yahoo Finance· 2 days agoThe FTSE 100 is close to where it started the day, despite losing almost 50 points in early trading....
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
Motley Fool via Yahoo Finance· 4 days agoLast year, it acquired NJOY, which is one of just three brands of FDA-authorized e-cigarettes on the...
Trump schedules a South Bronx rally
Politico· 4 days agoThis drew a heated rebuke from NYCHA spokesperson Barbara Brancaccio, who called him a “desperate fallen leader” who used “fear-mongering for political...
Harrison Butker Is Still Invited For Chiefs’ White House Visit
The Blast· 5 days agoFollowing Harrison Butker's controversial speech, the White House is providing an update on whether...
Céline Dion Nearly Died Amid Battle With Stiff-Person Syndrome
E! News via Yahoo News· 19 hours agoCéline Dion shared insight into her battle with stiff-person syndrome, including how she nearly died...
CXApp Inc. (Nasdaq: CXAI) Reschedules First Quarter 2024 Financial Results and Business Update...
Digital Journal· 3 days agoThese forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Factors that may cause such differences ...
Primary 2024: Any problems at the polls? Who's ahead? Follow live updates
Gannett via AOL· 3 days agoChatham, Bryan and Effingham voters head to the polls today to cast their votes to determine which...
Third time will be the Emmy charm for ‘The Morning Show’
Gold Derby via Yahoo News· 2 days agoApple TV’s flagship series “The Morning Show” returned last fall for a third season with Jennifer...
TODAY'S TEEN 2024: Abigail McGovern of Bradford High School
Kenosha News· 2 days agoName: Abigail McGovern
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
Digital Journal· 7 days agoGeoVax's lead infectious disease candidate is GEO-CM04S1, a next-generation Covid-19 vaccine targeting high-risk immunocompromised patient populations.